Friday, Feb 20th
Last update09:32:12 AM GMT
Mosquito-borne disease kills nearly 1 million people, mostly African children, every year. Results from two phase II trials in Africa show that a new malaria vaccine is effective at preventing both infection and the mosquito-borne disease itself in infants and children.
 NYU Langone Health, one of New York City’s major hospital networks, announced this week that it... |
 The U.S. government has given an ultimatum to the international group that helps provide vaccines to... | ||
|
|
